author-photo

Svetlana Shchegrova

Natera

23

Papers

538

Citations

Citation Trend

Filter By

Papers (17) Sort By

Journal Conference Others

Personalized, ctDNA analysis to detect minimal residual disease and identify patients at high risk of relapse with multiple myeloma.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Detection of Molecular Residual Disease Using Personalized Circulating Tumor DNA Assay in Patients With Colorectal Cancer Undergoing Resection of Metastases

2021
Show All
- Source
- Cite
- Save
Citations (2)
MA07.06 Circulating Tumor DNA for Monitoring Minimal Residual Disease and Early Detection of Recurrence in Early Stage Lung Cancer

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PD9-02: Personalized ctDNA as a predictive biomarker in high-risk early stage breast cancer (EBC) treated with neoadjuvant chemotherapy (NAC) with or without pembrolizumab (P)

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Circulating tumor DNA to detect minimal residual disease, response to adjuvant therapy, and identify patients at high risk of recurrence in patients with stage I-III CRC.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab

2020
Show All
- Source
- Cite
- Save
Citations (60)
420P Minimal residual disease detection and tracking tumour evolution using ctDNA in stage I-III colorectal cancer patients

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)
FACTORS INFLUENCING BACKGROUND CELL-FREE DNA LEVELS: IMPLICATIONS FOR DONOR DERIVED CELL-FREE DNA ASSESSMENT IN TRANSPLANT PATIENTS

2020 Transplantation
Show All
- Source
- Cite
- Save
Citations (2)
405MO Personalized circulating tumour DNA assay for the detection of minimal residual disease in CRC patients after resection of metastases

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (25)